Conversely, reduced SOD2 expression in early-stage PTEN-null thyroid and pancreatic carcinogenesis models increases DNA damage and tumor initiation, indicating a tumor-suppressive role during early malignant transformation [177]. The gene discussed is SOD2; the disease is neoplasm.